Khalid Syed I, Kelly Ryan, Khalid Ridha, Wu Rita, Ni Amilia Y, Adogwa Owoicho, Cheng Joseph
Department of Surgery, Rush University Medical Center, Chicago, IL.
Department of Neurosurgery, Rush University Medical Center, Chicago, IL.
Surg Open Sci. 2019 Sep 11;2(2):96-100. doi: 10.1016/j.sopen.2019.05.008. eCollection 2020 Apr.
The Centers for Disease Control and Prevention have declared that the United States is amidst a continuing opioid epidemic, with drug overdose-related death tripling between 1999 and 2014. Among the 47,055 overdose-related deaths that occurred in 2014, 28,647 (60.9%) of them involved an opioid.
To determine if there are specific trends in opioid prescribing practices of specific groups of surgeons to better describe any regional or subspecialty trends that exist, the Part D Prescriber Public Use File was used to evaluate all prescription drug orders for Medicare beneficiaries with a Part D prescription drug plan for the 2015 calendar year. Only those providers with the specialty description corresponding to a surgical specialty were included in this study, using the provider's Part B claims.
A total of 65,277,932 claims made to Part D by 90,253 surgeons in the 2015 service year were analyzed in this study, demonstrating statistically significant differences in the opioid prescribing practices of surgeons from different states, cities, practice settings, and subspecialties ( < .05). During this year, these surgeons' opioid medication claims cost the health care system $133,091,997.81 in drug benefits.
All health professionals with opiate prescribing privileges are entrusted with and responsible for the use of these medications; therefore, physicians have a crucial role in ensuring safe and effective use of this treatment option and the deterrence of its abuse. This is true in particular for surgeons given the acuity level and context of their practice.
美国疾病控制与预防中心宣称，美国正处于持续的阿片类药物泛滥之中，1999年至2014年间与药物过量相关的死亡人数增加了两倍。在2014年发生的47,055例与过量用药相关的死亡中，有28,647例（60.9%）涉及阿片类药物。
为了确定特定外科医生群体在阿片类药物处方行为上是否存在特定趋势，以更好地描述现有的任何地区或亚专业趋势，我们使用了D部分处方者公共使用文件来评估2015日历年参加D部分处方药计划的医疗保险受益人的所有处方药订单。本研究仅纳入了那些专业描述与外科专业相对应的提供者，数据来源于提供者的B部分索赔。
本研究分析了2015服务年度90,253名外科医生向D部分提出的共计65,277,932份索赔，结果显示来自不同州、城市、执业环境和亚专业的外科医生在阿片类药物处方行为上存在统计学显著差异（<0.05）。在这一年中，这些外科医生的阿片类药物索赔使医疗保健系统在药物福利方面花费了133,091,997.81美元。
所有拥有阿片类药物处方特权的医疗专业人员都被赋予并负责这些药物的使用；因此，医生在确保安全有效地使用这种治疗选择以及防止其滥用方面起着至关重要的作用。鉴于外科医生的执业敏锐度和背景情况，这一点尤为重要。
